{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:19:15Z","timestamp":1768439955565,"version":"3.49.0"},"reference-count":36,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background: Acute respiratory distress syndrome (ARDS), recognized as an inflammatory and life-threatening lung injury, is typified by severe hypoxaemia, lack of heart-related pulmonary edema, and bilateral lung infiltrates. Glucocorticoids are anti-inflammatory and immunoregulatory agents that are considered a viable treatment for ARDS. This study sought to contrast the effects of methylprednisolone, hydrocortisone, and dexamethasone at equivalent doses in ARDS. Methods: About 195 ARDS patients were allocated at random to take methylprednisolone (1 mg\/kg\/day), hydrocortisone (350 mg\/day), or dexamethasone (13 mg\/day). The primary and secondary outcomes over 28 days following the initiation of glucocorticoid therapy involved mortality, ventilator-free days, duration of hospitalization, duration of intensive care unit (ICU), total number of patients requiring invasive mechanical ventilation, and changes in the means of arterial oxygen partial pressure to inspired oxygen fraction (PaO2\/FiO2) and oxygen saturation percentage to inspired oxygen fraction (SpO2\/FiO2) ratios. Results: Over the 28-day follow-up, regarding mortality, there was a significant difference between dexamethasone and hydrocortisone, as well as between methylprednisolone and hydrocortisone. However, methylprednisolone exhibited the lowest mortality. There were no significant differences among study groups in ventilator-free days, hospitalization duration, ICU duration, and requirement for invasive mechanical ventilation. On the other hand, methylprednisolone had the lowest means of both durations of hospitalization and ICU, and the lowest requirement for invasive mechanical ventilation. Each study group exhibited a significant increase in both PaO2\/FiO2 and SpO2\/FiO2 ratios at follow-up time. However, dexamethasone showed the highest means of both PaO2\/FiO2 and SpO2\/FiO2 ratios at follow-up time. There was a significant difference in PaO2\/FiO2 and SpO2\/FiO2 ratios at follow-up assessment between dexamethasone and hydrocortisone. Conclusions: At equivalent doses, treating ARDS with methylprednisolone may be more successful than using dexamethasone and hydrocortisone.<\/jats:p>","DOI":"10.3390\/ph19010147","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:12:04Z","timestamp":1768403524000},"page":"147","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Comparative Study of Glucocorticoids Efficacy in Acute Respiratory Distress Syndrome"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4916-4359","authenticated-orcid":false,"given":"Marian S.","family":"Boshra","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62511, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9005-8412","authenticated-orcid":false,"given":"Mahmoud","family":"Ezzat","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Fayoum University, Fayoum 63511, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Department of Chest Diseases, Faculty of Medicine, Fayoum University, Fayoum 63511, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6973-5676","authenticated-orcid":false,"given":"Mona Y.","family":"Alsheikh","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0503-685X","authenticated-orcid":false,"given":"Raghda R. S.","family":"Hussein","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62511, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3261-0327","authenticated-orcid":false,"given":"Marwa","family":"Kamal","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Fayoum University, Fayoum 63511, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"ref_1","unstructured":"Diamond, M., Peniston, H.L., Sanghavi, D.K., and Mahapatra, S. (2024). Acute respiratory distress syndrome. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(22)01485-4","article-title":"Acute respiratory distress syndrome: Causes, pathophysiology, and phenotypes","volume":"400","author":"Bos","year":"2022","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Huppert, L.A., Matthay, M.A., and Ware, L.B. (2019). Pathogenesis of acute respiratory distress syndrome. Seminars in Respiratory and Critical Care Medicine, Thieme Medical Publishers.","DOI":"10.1055\/s-0039-1683996"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40560-020-00464-1","article-title":"Use of glucocorticoids in patients with acute respiratory distress syndrome: A meta-analysis and trial sequential analysis","volume":"8","author":"Zayed","year":"2020","journal-title":"J. Intensive Care"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13054-023-04572-w","article-title":"Management of severe acute respiratory distress syndrome: A primer","volume":"27","author":"Grotberg","year":"2023","journal-title":"Crit. Care"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13054-021-03546-0","article-title":"Decreased mortality in acute respiratory distress syndrome patients treated with corticosteroids: An updated meta-analysis of randomized clinical trials with trial sequential analysis","volume":"25","author":"Lin","year":"2021","journal-title":"Crit. Care"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e14645","DOI":"10.1111\/ijcp.14645","article-title":"Efficacy and safety of corticosteroids in acute respiratory distress syndrome: An overview of meta-analyses","volume":"75","author":"Rashid","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/phar.2637","article-title":"Corticosteroid use in ARDS and its application to evolving therapeutics for coronavirus disease 2019 (COVID-19): A systematic review","volume":"42","author":"Landolf","year":"2022","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zhang, L., Wang, Z., Xu, F., Retn, Y., Wang, H., Han, D., Lyu, J., and Yin, H. (2021). The Role of Glucocorticoids in the Treatment of ARDS: A Multicenter Retrospective Study Based on the eICU Collaborative Research Database. Front. Med., 8.","DOI":"10.3389\/fmed.2021.678260"},{"key":"ref_10","first-page":"4913","article-title":"Effect of glucocorticoids on mortality in patients with acute respiratory distress syndrome: A meta-analysis","volume":"18","author":"Zhao","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_11","first-page":"4637","article-title":"Effect of different doses and time-courses of corticosteroid treatment in patients with acute respiratory distress syndrome: A meta-analysis","volume":"18","author":"Sun","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_12","first-page":"7068762","article-title":"Effectiveness of Glucocorticoids in Acute Respiratory Distress Syndrome: An Umbrella Review","volume":"2021","author":"Abate","year":"2021","journal-title":"Crit. Care Res. Pract."},{"key":"ref_13","first-page":"276","article-title":"Corticosteroids for patients with acute respiratory distress syndrome: A systematic review and meta-analysis of randomized trials","volume":"130","author":"Mammen","year":"2020","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e00596","DOI":"10.1002\/rcr2.596","article-title":"High-dose, short-term corticosteroids for ARDS caused by COVID-19: A case series","volume":"8","author":"So","year":"2020","journal-title":"Respirol. Case Rep."},{"key":"ref_15","first-page":"1302","article-title":"Meta-analysis and trials sequential analysis for the efficacy and safety of low-and medium-dose glucocorticoids in adult acute respiratory distress syndrome patients","volume":"33","author":"Li","year":"2021","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.advms.2021.04.002","article-title":"Role of the early short-course corticosteroids treatment in ARDS caused by COVID-19: A single-center, retrospective analysis","volume":"66","author":"Boglione","year":"2021","journal-title":"Adv. Med. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"Dexamethasone treatment for the acute respiratory distress syndrome: A multicentre, randomised controlled trial","volume":"8","author":"Villar","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: The CoDEX randomized clinical trial","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s13054-016-1511-2","article-title":"Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: Results of a randomized controlled trial","volume":"20","author":"Tongyoo","year":"2016","journal-title":"Crit. Care"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jointm.2024.02.002","article-title":"Glucocorticoid therapy for acute respiratory distress syndrome: Current concepts","volume":"4","author":"Zhao","year":"2024","journal-title":"J. Intensive Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00540-021-03016-5","article-title":"Steroid treatment in patients with acute respiratory distress syndrome: A systematic review and network meta-analysis","volume":"36","author":"Yoshihiro","year":"2022","journal-title":"J. Anesth."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kuperminc, E., Heming, N., Carlos, M., and Annane, D. (2023). Corticosteroids in ARDS. J. Clin. Med., 12.","DOI":"10.3390\/jcm12093340"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e13496","DOI":"10.1111\/eci.13496","article-title":"Glucocorticoids for acute respiratory distress syndrome: A systematic review with meta-analysis and trial sequential analysis","volume":"51","author":"Zhen","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e39239","DOI":"10.1097\/MD.0000000000039239","article-title":"Association between glucocorticoid administration and outcomes in patients with ARDS based on the MIMIC-III database","volume":"103","author":"Lu","year":"2024","journal-title":"Medicine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"173947","DOI":"10.1016\/j.ejphar.2021.173947","article-title":"No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial","volume":"897","author":"Jamaati","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13613-020-0642-4","article-title":"Impact of corticosteroid treatment on clinical outcomes of influenza-associated ARDS: A nationwide multicenter study","volume":"10","author":"Tsai","year":"2020","journal-title":"Ann. Intensive Care"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5144\/0256-4947.2024.167","article-title":"Clinical outcomes of corticosteroid administration for acute respiratory distress syndrome in adults based on meta-analyses and trial sequential analysis","volume":"44","author":"Wu","year":"2024","journal-title":"Ann. Saudi Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s43162-022-00113-z","article-title":"Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients","volume":"34","author":"Saeed","year":"2022","journal-title":"Egypt. J. Intern. Med."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Abdelkader, A.A., Alsfouk, B.A., Saleh, A., Abdelrahim, M.E.A., and Saeed, H. (2024). Comparative Efficacy of Inhaled and Intravenous Corticosteroids in Managing COVID-19-Related Acute Respiratory Distress Syndrome. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16070952"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"hcaa039.060","DOI":"10.1093\/qjmed\/hcaa039.060","article-title":"Effectiveness and Outcome of Methylprednisolone versus Hydrocortisone in Treatment of Acute Respiratory Distress Syndrome (ARDS)","volume":"113","author":"Elbrassi","year":"2020","journal-title":"QJM: Int. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"E03","DOI":"10.3138\/cim.v46i4e03","article-title":"Efficacy and Safety of Glucocorticoid in the Treatment of Acute Respiratory Distress Syndrome caused by Covid-19: A Systematic Review and Meta-Analysis","volume":"46","author":"Jiang","year":"2024","journal-title":"Clin. Investig. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12931-022-02186-4","article-title":"Safety and efficacy of corticosteroids in ARDS patients: A systematic review and meta-analysis of RCT data","volume":"23","author":"Chang","year":"2022","journal-title":"Respir. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s10354-022-00993-4","article-title":"Comparison of the efficacy of equivalent doses of dexamethasone, methylprednisolone, and hydrocortisone for treatment of COVID-19-related acute respiratory distress syndrome: A prospective three-arm randomized clinical trial","volume":"173","author":"Taher","year":"2023","journal-title":"Wien. Med. Wochenschr"},{"key":"ref_34","first-page":"2526","article-title":"Acute respiratory distress syndrome: The Berlin Definition","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40560-022-00615-6","article-title":"ARDS clinical practice guideline 2021","volume":"10","author":"Tasaka","year":"2022","journal-title":"J. Intensive Care"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1164\/rccm.202311-2011ST","article-title":"An update on management of adult patients with acute respiratory distress syndrome: An official American thoracic society clinical practice guideline","volume":"209","author":"Qadir","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/1\/147\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:17:33Z","timestamp":1768403853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/1\/147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["ph19010147"],"URL":"https:\/\/doi.org\/10.3390\/ph19010147","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]}}}